The University of Alabama at Birmingham is a public research university in Birmingham, Alabama. Developed from an academic extension center established in 1936, the institution became a four-year campus in 1966 and a fully autonomous university in the University of Alabama System in 1969.

During the past decade, UAB Lung Health Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 12 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UAB Lung Health Center" #1 sponsor was "University of Alabama at Birmingham" with 12 trials, followed by "Boston Scientific Corporation" with 3 trials sponsored, "Aeris Therapeutics" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "FibroGen" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UAB Lung Health Center" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 6 trials as a collaborator, "Mereo BioPharma" with 2 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator, "PneumRx, Inc." with 2 trials as a collaborator and "American Lung Association" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "UAB Lung Health Center" are "Chronic Obstructive Pulmonary Disease" (6 trials), "Asthma" (4 trials), "Emphysema" (3 trials), "Chronic Bronchitis" (2 trials) and "Pulmonary Disease, Chronic Obstructive" (2 trials). Many other conditions were trialed in "UAB Lung Health Center" in a lesser frequency.

Most popular intervention types in "UAB Lung Health Center" are "Drug" (14 trials), "Device" (5 trials), "Behavioral" (2 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "placebo" (2 trials), "Acthar Gel" (1 trials), "Active Hand Sanitizer" (1 trials) and "Alair System" (1 trials). Other intervention names were less common.

The vast majority of trials in "UAB Lung Health Center" are 25 trials for "All" genders.

Currently, there are NaN active trials in "UAB Lung Health Center". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in UAB Lung Health Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in UAB Lung Health Center, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 9 trials that are defined as “Not Applicable".